Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306255576> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4306255576 abstract "Abstract Background Recently, a novel genetic-based classification for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) has been proposed to distinguish “typical” (RYR2 and CASQ2 genes) and “atypical” (TRDN, TECRL, CALM1–3, RYR2 loss-of-function [RYR2-LoF]) CPVT variants. Although some genetic forms were reported as malignant forms of CPVT, natural history data comparing typical and atypical CPVT variants are lacking. Purpose We compared the natural history of “typical” and “atypical” forms of CPVT in a large cohort of patients with genetically confirmed CPVT. Methods CPVT was diagnosed according to the criteria defined in the 2015 European Society of Cardiology Guidelines. Based on the genetic background, we classified the patients in two groups: 1) “Typical” CPVT (i.e., carriers of pathogenic or likely pathogenic mutations in RYR2 and CASQ2 genes); 2) “Atypical” CPVT (i.e., carriers of pathogenic or likely pathogenic mutations in TRDN, TECRL, CALM1–3 and RYR2-LoF). Patients with mutations in the CALM1, CALM2 or CALM3 were not identified in our cohort. The outcome was the occurrence of a life-threatening arrhythmic event (LAE), defined as: sudden cardiac death, aborted cardiac arrest or hemodynamically non-tolerated ventricular tachycardia. The Kaplan-Meier life-table method was used to determine the cumulative probability of experiencing a first LAE before the age of 40 years and in the absence of treatment. Outcomes in two groups were compared using the log-rank test. Results The study cohort included 238 patients (56% females, median age at diagnosis 14 years [IQR: 9–28 years]), of whom 226/238 (95%) patients with “typical” CPVT (216 RYR2, 10 CASQ2), and 12/238 (5%) patients with “atypical” CPVT (5 RYR2-LoF, 4 TRDN, 3 TECRL). In the entire population, the cumulative probability of experiencing a first LAE between birth and the diagnosis of CPVT was 2.3%, 21.2 and 40.8% at 5, 20, and 40 years, respectively. At any given age, the probability of a first LAE in the absence of therapy was significantly higher in patients with atypical CPVT (25%, 36%, and 100% at 5, 20, and 40 years, respectively), as compared to patients with typical CPVT (1%, 20%, and 39% at 5, 20, and 40 years, respectively; p=0.003, Figure 1). Patients with atypical CPVT suffered LAEs in early childhood (i.e., by the age of 5 years) significantly more often than patients with typical CPVT (3/5 patients [60%] in atypical CPVT vs. 2/43 patients [5%] in typical CPVT, p<0.001; Figure 2). Conclusions The natural history of CPVT is modulated by the genetic cause. Atypical CPVT variants are rare but are characterized by a worse outcome and a greater likelihood of experiencing an LAE since the early childhood, as compared to typical CPVT. Funding Acknowledgement Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ricerca Corrente funding scheme of the Italian Ministry of Health" @default.
- W4306255576 created "2022-10-15" @default.
- W4306255576 creator A5006513124 @default.
- W4306255576 creator A5010776107 @default.
- W4306255576 creator A5017303171 @default.
- W4306255576 creator A5018609711 @default.
- W4306255576 creator A5024226305 @default.
- W4306255576 creator A5024788938 @default.
- W4306255576 creator A5028768895 @default.
- W4306255576 creator A5056766952 @default.
- W4306255576 creator A5065720395 @default.
- W4306255576 creator A5067222669 @default.
- W4306255576 creator A5071398575 @default.
- W4306255576 creator A5073637341 @default.
- W4306255576 date "2022-10-01" @default.
- W4306255576 modified "2023-09-28" @default.
- W4306255576 title "Natural History of Patients with Typical and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia" @default.
- W4306255576 doi "https://doi.org/10.1093/eurheartj/ehac544.674" @default.
- W4306255576 hasPublicationYear "2022" @default.
- W4306255576 type Work @default.
- W4306255576 citedByCount "0" @default.
- W4306255576 crossrefType "journal-article" @default.
- W4306255576 hasAuthorship W4306255576A5006513124 @default.
- W4306255576 hasAuthorship W4306255576A5010776107 @default.
- W4306255576 hasAuthorship W4306255576A5017303171 @default.
- W4306255576 hasAuthorship W4306255576A5018609711 @default.
- W4306255576 hasAuthorship W4306255576A5024226305 @default.
- W4306255576 hasAuthorship W4306255576A5024788938 @default.
- W4306255576 hasAuthorship W4306255576A5028768895 @default.
- W4306255576 hasAuthorship W4306255576A5056766952 @default.
- W4306255576 hasAuthorship W4306255576A5065720395 @default.
- W4306255576 hasAuthorship W4306255576A5067222669 @default.
- W4306255576 hasAuthorship W4306255576A5071398575 @default.
- W4306255576 hasAuthorship W4306255576A5073637341 @default.
- W4306255576 hasBestOaLocation W43062555761 @default.
- W4306255576 hasConcept C113217602 @default.
- W4306255576 hasConcept C126322002 @default.
- W4306255576 hasConcept C163276114 @default.
- W4306255576 hasConcept C164705383 @default.
- W4306255576 hasConcept C190712762 @default.
- W4306255576 hasConcept C2775935837 @default.
- W4306255576 hasConcept C2776331378 @default.
- W4306255576 hasConcept C2778178275 @default.
- W4306255576 hasConcept C519063684 @default.
- W4306255576 hasConcept C71924100 @default.
- W4306255576 hasConcept C72563966 @default.
- W4306255576 hasConceptScore W4306255576C113217602 @default.
- W4306255576 hasConceptScore W4306255576C126322002 @default.
- W4306255576 hasConceptScore W4306255576C163276114 @default.
- W4306255576 hasConceptScore W4306255576C164705383 @default.
- W4306255576 hasConceptScore W4306255576C190712762 @default.
- W4306255576 hasConceptScore W4306255576C2775935837 @default.
- W4306255576 hasConceptScore W4306255576C2776331378 @default.
- W4306255576 hasConceptScore W4306255576C2778178275 @default.
- W4306255576 hasConceptScore W4306255576C519063684 @default.
- W4306255576 hasConceptScore W4306255576C71924100 @default.
- W4306255576 hasConceptScore W4306255576C72563966 @default.
- W4306255576 hasIssue "Supplement_2" @default.
- W4306255576 hasLocation W43062555761 @default.
- W4306255576 hasOpenAccess W4306255576 @default.
- W4306255576 hasPrimaryLocation W43062555761 @default.
- W4306255576 hasRelatedWork W2142547598 @default.
- W4306255576 hasRelatedWork W2201745004 @default.
- W4306255576 hasRelatedWork W236717508 @default.
- W4306255576 hasRelatedWork W2420071309 @default.
- W4306255576 hasRelatedWork W2559783075 @default.
- W4306255576 hasRelatedWork W2895547335 @default.
- W4306255576 hasRelatedWork W3003424136 @default.
- W4306255576 hasRelatedWork W3032963918 @default.
- W4306255576 hasRelatedWork W3129419069 @default.
- W4306255576 hasRelatedWork W4307024424 @default.
- W4306255576 hasVolume "43" @default.
- W4306255576 isParatext "false" @default.
- W4306255576 isRetracted "false" @default.
- W4306255576 workType "article" @default.